On October 7, 2025, Spruce Biosciences, Inc. entered into a Securities Purchase Agreement to raise approximately $50 million by selling 502,181 shares at $68.00 each and pre-funded warrants to purchase 233,144 additional shares, expected to close on October 9, 2025.